Guidelines for the diagnostic and therapeutic management of patients with gastro-oesophageal reflux disease

Italian Journal of Gastroenterology and Hepatology

Volumn 30, Issue 1, 1998, Pages 107-112

  Baldi, F ^a   Crotta, S ^a   Penagini, R ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Diagnosis; Gastro oesophageal reflux disease; Treatment

Indexed keywords

ALGINIC ACID; ANTACID AGENT; CISAPRIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR; SUCRALFATE;

ARTICLE; BARRETT ESOPHAGUS; ENDOSCOPIC BIOPSY; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HUMAN; PRACTICE GUIDELINE; WEIGHT REDUCTION;

CLINICAL TRIALS; ENDOSCOPY, DIGESTIVE SYSTEM; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; TREATMENT OUTCOME;

EID: 0031953852     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Armstrong D, Fraser R. Diagnosis and assessment of gastro-oesophageal reflux disease. Gullett 1993:3:31-41.
2. Karhilas PJ, Quigley EMM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996:110:1982-96.
3. ' Klinkenberg-Knol EC, Jansen JMBJ, Festen HPM, Meuwissen SGM, Lamers CBHW. Double-blind multicentre comparison of omeprazolc and ranitidine in the treatment of reflux oesophagitis. Lancet 1987:1:349-51.
4. Hetzel DJ, Dent J, Reed WD, Narielvala FM. McKinnon M, McCarthy JH, et al. Healing and relapse of severe peptic csophagitis after treatment with omeprazole. Gastroentcrology 1988:95:903-12.
5. Sontag SJ, Hirschowitz Bl, Holt S, Robinson MO. Behar J, Berenson MM, et al. Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. multicenter study. Gastroenterology 1992; 102:109-18.
6. Chiba N, De Gara J. Wilkinson JM, Hunt R. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997;! 12:1798-810.
7. Schindlebeck NE, Klauser AG, Berghammer G, London W\V, Muller-Lissner SA. Three years follow-up of patients with gastroesophageal reflux disease. Gut 1992;33:1016-19.
8. McDougall NI, Johnston BT, Kee F, Collins JSA, McFarland RJ, Love AHG. Natural history of reflux esophagitis: a 10 year follow-up of its effect on patient symptomatoloay and quality of life. Gut 1996;38:481-6.
9. Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Mod 1995;333:1106-10.
10. Robinson M. Lanza F, Avner D, Haber M. Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. A randomized double blind, placebo-controlled trial. Ann Intern Med 1996; 124:859-67.
11. Fennerty MB. Castell DO, Fendrick AM, Halpern M, Johnson D, Kahrilas PJ. et al. The diagnosis and treatment of gastroesophaaeal reflux disease in a managed care environment. Arch InternMed 1996; 156:477-84.
12. Spechler SJ. Goyal RK. Barren's esophasius. N End J Med 1986;315:362-71.
13. Gruppo Operative dello Studio delle Precancero.si Esofagcee (G.O.S.P.E.). editor. L'esofago di Barren. Milano, Segrate: Edizioni Ulisse. 1995.
14. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastro-ocsophaueal junction. Lancet 1994:344:1533-6.
15. Pera M, Cameron AJ, Trastek VF, Carpenter HA. Zinmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104:510-3.
16. Ferraris R, Bonclli L, Conio M, Fracchia M, Lapertosa G, Aste H and G.O.S.P.E. Incidence of Barren's adenocarcinoma in an Italian population: an endoscopie surveillance programme. Eur J Gastroenterol Hepatol !997;9:88I-5.
17. Provenzale D, Kemp JA, Arora S, Wong JB. A guide for surveillance of patients with Barren's esophaeus. Am J Gastroenterol I994;89:670-80.